search
Back to results

Effect of Sedation on Diagnostic Injections

Primary Purpose

Sacroiliac Joint Pain, Sympathetically Maintained Pain

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Midazolam
Fentanyl
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Sacroiliac Joint Pain focused on measuring sedation, sensitivity, specificity, validity, diagnostic injection

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic pain > 4 weeks but < 10 years in duration
  • Suspected SI joint or sympathetically-maintained pain based on history and physical exam
  • May benefit from a sacroiliac joint or sympathetic block
  • Pain on 0-10 NRS scale > 3/10 in intensity

Exclusion Criteria:

  • No previous interventional pain-alleviating injections for the same condition within the past 3 years
  • Uncontrolled coagulopathy
  • Pregnancy, which will be ruled out by a urine pregnancy test in women of childbearing age
  • Allergy to contrast dye or amide local anesthetics
  • Unstable medical or psychiatric condition (e.g. unstable angina, congestive heart failure or severe depression) that could preclude an optimal treatment response
  • Systemic infection
  • Age < 18 or > 75 years

Sites / Locations

  • Johns Hopkins Blaustein Pain Treatment Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Sedation

Control

Arm Description

Pt will receive sedation with their procedure

Patient will not receive sedation during procedure

Outcomes

Primary Outcome Measures

Pain Score
pain diary using 0-10 scale, with 0 being no pain and 10 being the worst pain imaginable

Secondary Outcome Measures

Pain Score
0-10 numerical rating scale (NRS) pain scale. 0 being no pain and 10 being the worst possible pain.
Procedure-related Pain Score
0-10 pain scale, with 0 being no pain and 10 being the worst pain imaginable
Oswestry Disability Index
Measure of functional capacity on a scale ranging from 0% to 100%, with 0% signifying no disability
Satisfaction
5-point Likert scale. The scale is from 1-5. 1 being very unsatisfied and 5 being very satisfied.

Full Information

First Posted
April 25, 2011
Last Updated
October 31, 2016
Sponsor
Johns Hopkins University
Collaborators
Walter Reed National Military Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01472835
Brief Title
Effect of Sedation on Diagnostic Injections
Official Title
Randomized, Cross-over Study Evaluating the Effect of Sedation on Pain Relief After Diagnostic Injections
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
February 2013 (Actual)
Study Completion Date
February 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Johns Hopkins University
Collaborators
Walter Reed National Military Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Interventional pain procedures have diagnostic, prognostic and therapeutic value. It is well-documented that the reference standard for identifying a pain generator is a low-volume block performed with local anesthetic, with or without steroid. Many factors may increase the false positive (FP) rate of diagnostic and prognostic nerve blocks; however, the use of sedation is the most controversial and remediable. Proponents of sedation argue that it has little effect on the rate of positive diagnostic blocks, and may even reduce the false-negative rate. The purpose of this study is to determine the effect of intravenous sedation on pain relief and the "false-positive rate" after diagnostic nerve blocks.
Detailed Description
Sixty-eight patients with sacroiliac (SI) joint or sympathetically-maintained pain will be randomized in a crossover fashion to receive diagnostic nerve blocks either with or without intravenous sedation. Among those who obtain some benefit and return for a 2nd block, this 2nd procedure will be done with sedation if the first was done without sedation, and vice versa. Midazolam and fentanyl will be used for intravenous sedation, titrated to anxiolysis and analgesia. Pain scores (0-10 numerical rating scale, or NRS) and an activity log will be recorded over the 8-hours following the blocks via a pain diary. The first follow-up visit will be 4 weeks after the procedure. Patients who obtain some benefit but continue to report significant pain or who might otherwise benefit from a repeat procedure will have this second procedure performed with sedation if no sedation was given for the first procedure, and without sedation if sedation was administered for the first procedure. The post-procedure pain data will be recorded in the same fashion as the initial nerve block. The second follow-up visit will be 4 weeks after the 2nd block.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sacroiliac Joint Pain, Sympathetically Maintained Pain
Keywords
sedation, sensitivity, specificity, validity, diagnostic injection

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
73 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sedation
Arm Type
Experimental
Arm Description
Pt will receive sedation with their procedure
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patient will not receive sedation during procedure
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Description
Used for anxiolysis
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
Used for analgesia and as a sedative
Primary Outcome Measure Information:
Title
Pain Score
Description
pain diary using 0-10 scale, with 0 being no pain and 10 being the worst pain imaginable
Time Frame
through 6 hours after injection
Secondary Outcome Measure Information:
Title
Pain Score
Description
0-10 numerical rating scale (NRS) pain scale. 0 being no pain and 10 being the worst possible pain.
Time Frame
1-month
Title
Procedure-related Pain Score
Description
0-10 pain scale, with 0 being no pain and 10 being the worst pain imaginable
Time Frame
1 day
Title
Oswestry Disability Index
Description
Measure of functional capacity on a scale ranging from 0% to 100%, with 0% signifying no disability
Time Frame
1-month
Title
Satisfaction
Description
5-point Likert scale. The scale is from 1-5. 1 being very unsatisfied and 5 being very satisfied.
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic pain > 4 weeks but < 10 years in duration Suspected SI joint or sympathetically-maintained pain based on history and physical exam May benefit from a sacroiliac joint or sympathetic block Pain on 0-10 NRS scale > 3/10 in intensity Exclusion Criteria: No previous interventional pain-alleviating injections for the same condition within the past 3 years Uncontrolled coagulopathy Pregnancy, which will be ruled out by a urine pregnancy test in women of childbearing age Allergy to contrast dye or amide local anesthetics Unstable medical or psychiatric condition (e.g. unstable angina, congestive heart failure or severe depression) that could preclude an optimal treatment response Systemic infection Age < 18 or > 75 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven P Cohen, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Blaustein Pain Treatment Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21205
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18042881
Citation
Cohen SP, Hurley RW. The ability of diagnostic spinal injections to predict surgical outcomes. Anesth Analg. 2007 Dec;105(6):1756-75, table of contents. doi: 10.1213/01.ane.0000287637.30163.a2.
Results Reference
background
PubMed Identifier
24524866
Citation
Cohen SP, Hameed H, Kurihara C, Pasquina PF, Patel AM, Babade M, Griffith SR, Erdek ME, Jamison DE, Hurley RW. The effect of sedation on the accuracy and treatment outcomes for diagnostic injections: a randomized, controlled, crossover study. Pain Med. 2014 Apr;15(4):588-602. doi: 10.1111/pme.12389. Epub 2014 Feb 13.
Results Reference
derived

Learn more about this trial

Effect of Sedation on Diagnostic Injections

We'll reach out to this number within 24 hrs